Human skull base chordoma LC-MSMS

ABSTRACT: The prognostic factors of skull base chordoma associated with outcomes of patients after surgical resection remain poorly defined. This project aimed to identify a novel prognostic factor for patients with skull base chordoma. Using a proteomics approach, we screened tumor biomarkersthat upregulated in the rapid-recurrence group of chordoma, narrowed down by bioinformatics analysis, and finally potential biomarker was chosen for validation by immunohistochemistry using tissue microarray.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Primary Cell

DISEASE(S): Brain Cancer

SUBMITTER: Yutao Shen  

LAB HEAD: Yazhuo Zhang

PROVIDER: PXD025894 | Pride | 2021-11-03

REPOSITORIES: Pride